Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis

Autor: Abrunhosa-Branquinho, André N., Bar-Deroma, Raquel, Collette, Sandra, Clementel, Enrico, Liu, Yan, Hurkmans, Coen W., Feuvret, Loïc, Van Beek, Karen, van den Bent, Martin, Baumert, Brigitta G., Weber, Damien C.
Zdroj: In Radiotherapy and Oncology May 2018 127(2):292-298
Databáze: ScienceDirect
Externí odkaz: